ArticlePharmacological research2021

Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.

Emilio Di Maria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.